Genelux Corp. (GNLX)
2.56
+0.04
(+1.59%)
USD |
NASDAQ |
Oct 02, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Genelux Price : 2.56 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 2.55 | 2.59 | 2.515 | 2.56 | 278256.0 |
| Oct 01, 2026 | 2.53 | 2.56 | 2.46 | 2.52 | 200938.0 |
| Sep 30, 2026 | 2.47 | 2.55 | 2.47 | 2.53 | 236871.0 |
| Sep 29, 2026 | 2.48 | 2.56 | 2.415 | 2.45 | 164898.0 |
| Sep 28, 2026 | 2.46 | 2.50 | 2.41 | 2.47 | 103751.0 |
| Sep 25, 2026 | 2.47 | 2.54 | 2.420 | 2.48 | 139874.0 |
| Sep 24, 2026 | 2.51 | 2.524 | 2.41 | 2.43 | 151994.0 |
| Sep 23, 2026 | 2.61 | 2.640 | 2.50 | 2.515 | 115793.0 |
| Sep 22, 2026 | 2.55 | 2.630 | 2.52 | 2.61 | 161803.0 |
| Sep 21, 2026 | 2.57 | 2.585 | 2.51 | 2.56 | 197287.0 |
| Sep 18, 2026 | 2.54 | 2.565 | 2.504 | 2.53 | 143118.0 |
| Sep 17, 2026 | 2.36 | 2.56 | 2.36 | 2.53 | 295280.0 |
| Sep 16, 2026 | 2.47 | 2.47 | 2.31 | 2.34 | 661723.0 |
| Sep 15, 2026 | 2.61 | 2.61 | 2.40 | 2.47 | 203405.0 |
| Sep 14, 2026 | 2.49 | 2.61 | 2.46 | 2.54 | 297586.0 |
| Sep 11, 2026 | 2.53 | 2.55 | 2.448 | 2.49 | 146908.0 |
| Sep 10, 2026 | 2.55 | 2.73 | 2.41 | 2.48 | 535584.0 |
| Sep 09, 2026 | 2.50 | 2.555 | 2.485 | 2.52 | 114100.0 |
| Sep 08, 2026 | 2.50 | 2.54 | 2.39 | 2.54 | 408293.0 |
| Sep 04, 2026 | 2.52 | 2.535 | 2.425 | 2.44 | 296535.0 |
| Sep 03, 2026 | 2.55 | 2.58 | 2.46 | 2.52 | 510441.0 |
| Sep 02, 2026 | 2.58 | 2.635 | 2.55 | 2.55 | 158138.0 |
| Sep 01, 2026 | 2.63 | 2.66 | 2.560 | 2.60 | 194990.0 |
| Aug 31, 2026 | 2.67 | 2.77 | 2.56 | 2.615 | 328487.0 |
| Aug 28, 2026 | 2.87 | 2.87 | 2.65 | 2.66 | 417798.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arcutis Biotherapeutics, Inc. | 25.16 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
Price Related Metrics
| PS Ratio | 13176.76 |
| PEG Ratio | -2.277 |
| Price to Book Value | 7.166 |
| Earnings Yield | -33.90% |
| Market Cap | 115.46M |
| PEGY Ratio | -2.277 |